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Abstract:
Antimicrobial resistance has become a great public health problem worldwide and multi-drug 
resistant Staphylococcus aureus has been widely reported. 
Methods: The presence or absence of methicillin resistance gene (mecA) in 48 clinical wound 
isolates of S. aureus was examined by the polymerase chain reaction (PCR). The results were 
analyzed in parallel to the disk diffusion method by oxacillin (1 µg). Polymerase chain reaction was 
amplified at a sequence of mecA gene at 1319 bp. 
Results: Nine (18.75%) out of the 48 isolates and were found to be identical to those of disk 
diffusion test. All strains were studied for their susceptibility to traditionally used antibiotics. The 
results revealed that multi-drug resistance was common among MRSA strains. The drug of choice 
for the treatment of MRSA and MSSA was vancomycin.
Conclusion: The study concluded that multiple antibiotic resistance was common, and the PCR 
assay can be used to confirm MRSA infection.
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esistance to methicillin was first 
described for Staphylococcus aureus
in 1960, shortly after the introduction 
of the drug into clinical practice
1
. Since then, 
methicillin-resistant S. aureus (MRSA) has 
become a widely recognized cause of 
morbidity and mortality throughout the 
world
2
.  Staphylococcal strains usually have 
penicillin-binding proteins (PBPs). In the 
absence of β-lactam antibiotics, the 
Staphyolococci utilize PBPs to synthesize the 
cell wall which is composed of 
peptidoglycan
3
. In contrast, an additional low-
affinity penicillin binding protein designated 
PBP 2a is encoded by a unique MRSA-PBP 
gene
4
 and is the main factor responsible for 
the expression of methicillin resistance
5
. The 
β-lactam resistance of MRSA to all β-lactam 
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Traditionally, methicillin or oxacillin has 
been tested and the results are representative 
of resistance to all β-lactam agents 
7
. Disk 
diffusion method against bacterial isolates has 
been used routinely for the choice of 
appropriate chemotherapy. In the case of 
MRSA strains, the disk diffusion is 
influenced by growth conditions, pH and 
NaCl 
8
. Therefore, it is important to find out 
whether the isolated S. aureus possesses 
MRSA-PBP gene, in order to confirm the 
results of the disk diffusion method. In this 
study the presence of MRSA-PBP gene in 
clinical isolates of S. aureus was investigated 
by comparing PCR results and disk diffusion 
method of oxacillin.
Materials and Methods
In this study, 48 S. aureus isolates 
were obtained from infected wound 
specimens, such as ulcers, burns, abscesses 
and post-operative wounds from Khartoum 
Teaching Hospital. S. aureus isolates were 
identified by the standard microbiological 
methods including gram strains, catalase, 
coagulase and DNase tests. MRSA was 
determined by the disk diffusion method to 
oxacillin according to the National 
R
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Antimicrobial susceptibility testing 
was performed by the disk diffusion method 
for cephalexin (30 µg), cotrimoxazole (25 
µg), clindamycin (20 µg), erythromycin (15 
µg), vancomycin (30 µg), tetracycline (30 
µg), rifampicin (5 µg), amoxycillin (10 µg), 
and ciprofloxacin (5 µg). A suspension of the 
tested organism was adjusted against 0.5 
MacFarland’s standard turbidity. It was then 
inoculated onto Mueller-Hinton agar, then 
incubated at 37 _C for 16-18 hours and 
examined for sensitivity. 
Genomic DNA was isolated by using 
chloroform DNA purification protocol. With 
1 µl loop, a small quantity of growth 
(equivalent to 2 small colonies) was mixed 
into 100 µl of sterile distilled water in a 
micro-centrifuge tube. Chloroform 100 µl 
(Sigma) was added, and the mixture was 
vortexed for 10 seconds. The mixture was 
heated at 80 _C for 20 minutes, after which it 
was held at -20 _C for another 20 minutes. 
The sample was allowed to thaw while still 
cold and was centrifuged at 12,000 g for 3 
minutes in a mini-centrifuge. The extracted 
DNA was stored at -20 _C ready for use 
10
.
Two 20-mer PCR primers of 
methicillin resistance (mecA) gene were 
chosen. These oligonucleotides were 
complementary to the target segment of the 
MRSA-PBP gene sequence as follows: primer 
MR1, 5’-GTG GAA TTG GCC AAT ACA 
GG- 3’ (478 TO 497) and primer MR2,  5’ 
TGA GTT CTG CAG TAC CGG AT- 3’ 
(1816 to 1797) 
11
. 
The PCR reaction mixture contained 
reaction buffer (10 µl), 500 U Taq DNA 
polymerase (Promega) (0.3 µl), 10 m/M 
dNTP mix (1 µl) 25 mM MgCl
2
 (3 µl), 10 
mM each primer (10 µl), template DNA (1 
µl), and distilled water (14.7 µl) to a final 
volume of 40 µl.
The amplification procedure was as 
follows: an initial step at 94 _C for 30 
seconds; 55 _C for 30 seconds and 72 _C for 
1 min (each step was repeated 40 times) and a 
final step at 72 _C for 4 minutes.
The amplification products were 
subjected to electrophoresis on 0.4% agarose 
gel with ethidium bromide incorporated for 
DNA strainsing. The PCR products were 
visualized and photographed on an UV trans-
illuminator and the bands of the PCR 
products were determined by using the 1 kb 
ladder DNA marker (Promega).
Results
Nine (18.75%) isolates out of the 48 S. 
aureus strains were resistant to oxacillin. The 
oxacillin resistant S. aureus was found to be 
identical by genotyping to the amplified DNA 
fragment of MRSA-PBP gene. None of the 
other 39 MSSA strains showed similar gene. 
The size of the DNA fragment was 1319 bp. 
(Fig 1).
Fig 1: Agarose gel electrophoresis of PCR 
products of mecA gene.
Lanes 1-4:Methicillin resistant S. aureus 
(1319 bp) DNA fragment.
Lanes 5-7: Methicillin sensitive S. aureus 
(MSSA).
Lane M: (1kb ladder) DNA marker.
All isolates were found to be sensitive 
to vancomycin (100%). The sensitivity for the 
other antibiotics was as follows: co-
trimoxazole 27 (56.25%), rifampicin 35 
(72.9%), clindamycin 33 (68.75%), 
tetracycline 16 (33.3%), erythromycin 31 
(64.6%), cephalexin 29 (60.4%), oxacillin 39 
(81.25%), amoxycillin 19 (39.6%) and 
ciprofloxacin 32 (66.7%).
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Twenty isolates (41.7%) including the 
nine MRSA showed multiple antibiotic 
resistances to four or more of the 
antimicrobial agents (Table 1). 
Table 1: Antibiotic resistances to four or more 
of the antimicrobial agents. 
Resistance MRSAMSSA Total(%)
Fully sensitive 0 0 0 (0)
Resistant to 1 agent 0 6 6 (12.5)
Resistant to 2 agents 0 9 9 (18.75)
Resistant to 3 agents 0 13 13 (27.1)
Resistant to 4 agents 0 6 6 (12.5)
Resistant to 5 agents 1 5 6 (12.5)
Resistant to 6 agents 3 0 3 (6.25)
Resistant to 7 agents 5 0 5 (10.4)
Total 9 39 48(100.0)
Discussion
Antimicrobial resistant and multi-drug 
resistant S. aureus have become a great public 
health problem worldwide. This study 
determined the pattern of resistance to the 
commonly used antibiotics for MRSA and 
MSSA. 
Multi-drug resistance to different 
antimicrobial agents among MRSA strains is 
significantly higher than MSSA. MRSA in 
nosocomial infections is among the most 




The frequency of antibiotic resistance 
among S. aureus in the current study was in 
accordance with other studies. The results 
from intensive care units showed that 78% of 
32 S. aureus isolates were with multiple 
antimicrobial resistances as follows: 12% co-
trimoxazole, 25% teicoplanin, 46% 
erythromycin, 50% clindamycin, 68% 
gentamicin, 71% ciprofloxacin, 81% 
oxacillin, and 100% penicillin resistant 
13
. 
Higher resistance of S. aureus isolates was 
reported in a study from Nigeria showing 
resistance to ampicillin 91.7%, clindamycin 
78.3%, cephalexin 75%, methicillin 71.7% 
and vancomycin 68.3%, but had very low 
resistance to Gentamicin 3.3%, ciprofloxacin 
3.3%, ofloxacin 3.3%, sparfloxacin 3.3%, and 
pefloxacin 10.0%. As many as 71.7% of the 
isolates in the current study showed multi-
drug resistances 
14
, whereas in Peru only 25% 




Table 2: Comparison between MRSA and MSSA in relation to antibiotic susceptibility.
Antibiotic ResistanceNo. of 
Isolates









































(R) Rifampicin, (Am) Amoxycillin, (T) Tetracycline, (Cl) Cephalexin, (Co) Co-trimoxazole, (E) 
Erythromycin, (Cp) Ciprofloxacin, (Cd) Clidamycin, (Va) Vancomycin, (Ox) Oxacillin.
MRSA strains were also resistant to 
multiple antibiotics in Algiers Hospitals. 
Isolates (97.6%) were resistant to kanamycin, 
86% to fusidic acid, 73% to tetracycline, 25% 
to erythromycin, 16% to ofloxacin, 11.3% to 
clindamycin, 7% to Gentamicin, 4.5% to 
pristinamycin, 2.3% to chloramphenicol, and 
2.3% to refampicin 
16
. The rate of antibiotic 
resistant strains of MRSA was higher 
for penicillin and cephalosporins in Japan, 
whereas over 95% of MRSA were resistant to 
amoxycillin and piperacillin. 
17
. In India, the 
resistance to all antibiotics tested among 
MRSA and MSSA were found to be 23.2% 
and 6.6% respectively. Higher resistance to 
multiple  antibiotics  in  MRSA  isolates  was 
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also reported 
18
. In Egypt, MRSA strains 




Since the emergence of MRSA in 
1960s, tiecoplanin and vancomycin were the 
drugs of choice and commonly used for the 
treatment of the Nosocomial MRSA and other 
gram positive infections 
20, 21
. In this study, 
the only antibiotic to which all MRSA and 
MSSA strains were still sensitive was 
vancomycin. These results are similar to the 




MRSA now commonly accounts for 
20% to 40% of all S. aureus isolates 
22
. 
Generally, high rates of about 71% have been 





, Peru 68% 
15





, and in the Latin America 31% 
27
. In 
India, methicillin resistance among the S. 
aureus isolates was 39.5% 
28
. Another 
important geographic difference for MRSA 
prevalence was also found in France, Spain 




S. aureus resistance to methicillin 
occurs when an isolate carries an altered PBP 
2a which is encoded by the mecA gene. The 
new PBP 2a binds β-lactam with lower 
affinity which results in resistance to this 
class of antimicrobial agents. In this study the 
conventional method for the determination of 
susceptibility to oxacillin was confirmed by 
the amplification of mecA gene by PCR. Nine 
out of 48 S. aureus isolated initially classified 
as methicillin resistance based on disk 
diffusion method were confirmed by the PCR 
to carry mecA gene. None of MSSA showed 
the mecA gene. Therefore, detection of mecA 
gene by the PCR is considered to be the gold 
standard assay for resistance.
Conclusion
In conclusion, the prevalence of the 
multiple antibiotic resistant MRSA was 
common in wound infections, and the 
injudicious use of antibiotics will lead to the 
development of more drug resistance. The 
PCR assay appears to be a very reliable and 
accurate test for the detection of MRSA-PBP.
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